This clinical trial is studying adult critically ill patients with severe vitamin D deficiency, a condition in which the body has very low levels of vitamin D and the person is seriously unwell. The study is testing colecalciferol, a form of vitamin D3, given as oral drops, and comparing it with placebo. The purpose of the study is to find out whether a high dose of vitamin D3 can improve recovery and reduce the chance of death in the first 28 days after treatment.

In this study, people receive either the vitamin D3 drops or placebo, and the care team follows their progress over time. The study looks at what happens during the hospital stay and after discharge, including survival, time in intensive care, time in the hospital, and later health problems such as infections, falls, fractures, and kidney stones. It also checks for possible side effects of high vitamin D, such as hypercalcemia, which means too much calcium in the blood.